Core/shell poly(ethylene oxide)/Eudragit fibers for site-specific release

Published in International Journal of Pharmaceutics, vol. 523(1), pp. 376–385 (2017) · Elsevier
DOI: 10.1016/j.ijpharm.2017.03.038

Summary

Delivering a drug to a specific part of the gut — rather than releasing it in the acidic stomach — calls for a coating that stays intact at low pH and opens further along the tract. This study uses coaxial electrospinning to build core/shell fibres with exactly that behaviour: a drug-loaded core of mucoadhesive poly(ethylene oxide) (PEO) surrounded by a shell of the pH-sensitive polymer Eudragit S100. Two model drugs were tested — acidic indomethacin and basic mebeverine hydrochloride — at several loadings (9–23% w/w of the core), with two PEO molecular weights explored for the latter. Electron microscopy confirmed distinct core and shell compartments and showed the drugs held in an amorphous state, while dissolution tests demonstrated the Eudragit shell strongly suppresses release under stomach-like acidic conditions — enabling site-specific, intestinal release.

Authors & Affiliations

Topics

Coaxial Electrospinning Site-Specific Drug Release pH-Responsive Fibers Core/Shell Structures

Materials

Poly(ethylene oxide) (PEO) Eudragit S100

Linari Electrospinning Systems

Coaxial electrospinning needles by Linari Nanotech
This core/shell architecture is produced by coaxial electrospinning. Linari Nanotech supplies coaxial (core-shell) needle emitters for encapsulating a drug-loaded core within a functional shell.
Read the full publication
Back to blog